Related Experiment Videos
Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: a prospective, nonrandomized pilot
Shlomo Melamed1, Guy J Ben Simon, Hana Levkovitch-Verbin
1The Sam Rothberg Glaucoma Center, Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel. melamed_shlomo@hotmail.com
Archives of Ophthalmology (Chicago, Ill. : 1960)
|July 16, 2003
Summary
Selective laser trabeculoplasty effectively lowers intraocular pressure in open-angle glaucoma patients. This safe primary treatment showed significant IOP reduction with minimal complications.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Laser Therapy
Background:
- Open-angle glaucoma and ocular hypertension require effective primary treatments.
- Selective laser trabeculoplasty (SLT) is a minimally invasive option.
Purpose of the Study:
- To assess the safety and efficacy of SLT as a first-line therapy for open-angle glaucoma and ocular hypertension.
Main Methods:
- 31 patients (45 eyes) with open-angle glaucoma or ocular hypertension underwent SLT.
- Ophthalmic evaluations, including IOP measurements, were performed pre- and post-treatment up to 18 months.
- Topical antiglaucoma medications were used as needed during follow-up.
Main Results:
- Mean intraocular pressure (IOP) decreased by 30% (7.7 mm Hg).
- 89% of eyes achieved at least a 5 mm Hg IOP reduction.
- Complications were mild and transient, with 4% non-response and 7% requiring medication at follow-up.
Conclusions:
- Selective laser trabeculoplasty is a safe and effective primary treatment for open-angle glaucoma and ocular hypertension.
- SLT demonstrates significant IOP-lowering capabilities with a favorable safety profile.